Exhibit 99.2

                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

         I, Chene Gardner, certify that:

          1. I have reviewed  this  Form 10-KSB of Cancer Therapeutics, Inc.;

          2. Based on my knowledge, this annual  report does not contain any
             untrue  statement of a material  fact or omit to state a material
             fact necessary to make the statements  made, in light of the
             circumstances under which such statements were made, not misleading
             with respect to the period covered by this annual report;

          3.  Based  on  my  knowledge,  the  financial  statements,  and  other
              financial information included in this annual report, fairly
              present in all material respects the financial condition, results
              of operations and cash flows of the registrant as of, and for, the
              period presented in this annual report;

          4. The registrant's  other  certifying  officers and I are responsible
             for establishing and maintaining disclosure controls and procedures
             (as defined in Exchange Act Rules 13a-14 and 15d-14)for the
             registrant and have:

               a) designed such disclosure controls and procedures to ensure
                  that material information relating to the registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this annual report is being prepared;

               b) evaluated the effectiveness of the registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of this annual report (the "Evaluation
                  Date"); and

               c) presented in this annual report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date;

          5. The registrant's  other  certifying  officers and I have disclosed,
             based on our most recent evaluation, to the registrant's auditors
             and the audit committee of registrant's board of directors (or
             persons performing the equivalent function):

                a) all significant deficiencies in the design or operation of
                   internal controls which could adversely affect the
                   registrant's ability to record, process, summarize and report
                   financial data and have identified for the registrant's
                   auditors any material weaknesses in internal controls; and

                b) any fraud, whether or not material, that involves management
                   or other employees who have a significant role in the
                   registrant's internal controls; and

          6. The registrant's other certifying  officers and I have indicated in
             this annual report whether or not there were significant changes
             in internal controls or in other factors that could significantly
             affect internal controls subsequent to the date of our most recent
             evaluation, including any corrective actions with regard to
             significant deficiencies and material weaknesses.

Dated as of January 15, 2007

                                                By     /s/ Chene Gardner
                                                -------------------------------
                                                Chene Gardner
                                                Chief Financial Officer